eMedicine Specialties > Urology > Infections and Related Inflammatory Conditions

Chronic Bacterial Prostatitis: Differential Diagnoses & Workup

Author: Sunil K Ahuja, MD, Chief of Minimally Invasive Urology, Department of Urology, Staff Urologist, Santa Teresa Community Hospital
Contributor Information and Disclosures

Updated: Mar 13, 2008

Differential Diagnoses

Nonbacterial Prostatitis
Prostate Cancer: Biology, Diagnosis, Pathology, Staging, and Natural History
Prostatitis, Bacterial
Urethral Strictures
Urethritis

Other Problems to Be Considered

Acute prostatitis
Prostatic stones
Anatomic obstruction due to prostatic hyperplasia, urinary stricture disease, or bladder neck dysfunction

Workup

Laboratory Studies

  • Microscopic examination  
    • Commonly, chronic prostatitis (category II in the 1995 NIH prostatitis classification system) is diagnosed after microscopic examination of the EPS and a positive culture finding after a prostatic massage. If a patient presents with symptoms of an acute urinary tract infection and/or the patient is febrile, an EPS should not be obtained because the patient likely has acute prostatitis. In this situation, a vigorous prostatic massage may result in urinary sepsis.
    • The generally accepted level of WBCs in an EPS for a diagnosis of chronic prostatitis (category II) is more than 10 WBCs/hpf (40X objective) or an observation of clumping WBCs with the presence of oval fat bodies and a positive EPS culture finding. Category III prostatitis is divided into IIIa and IIIb based on whether greater or fewer than 10 WBCs are seen on microscopic examination of the EPS, respectively. However, the management approaches for these two categories do not differ.
    • Finding WBCs in an EPS is not diagnostic of chronic bacterial prostatitis (CBP) because this finding is commonly associated with nonbacterial prostatitis, urethritis, prostatic stones, or recent ejaculation. 
  • Positive urine culture findings after a prostatic massage  
    • Performing this procedure helps confirm the diagnosis of CBP.
    • The classic 4-glass Meares-Stamey test for localization of the infection to the prostate is cumbersome and impractical. A more sensitive and practical test that is simpler to perform is preprostatic and postprostatic massage urine culture.2
    • The ejaculate can also be cultured. This may indicate a prostatic infectious source.
    • Carefully observe the culture for a colony count that is 10 times higher in the postprostatic massage culture compared to the preprostatic massage culture, which confirms CBP. This is the widely accepted standard.
    • Perform the prostatic massage during the rectal examination by kneading the prostate from front to back and from lateral to medial until a milky fluid is obtained from the urethra. This may require as long as a minute of fairly vigorous massage; therefore, inform the patient of the intended plan and goal. Sometimes, milking the urethra hastens the appearance of the fluid. Then, touch the fluid to a microscopic slide for examination.
    • The pH of prostatic fluid rises when infection is present, from 6.5 to higher than 8.0.
    • Prostate-specific antigen (PSA) levels are often elevated. Do not construe this finding as an elevation associated with prostate cancer unless the level remains elevated after repeat testing. Repeat testing should be performed 6 weeks after resolution of the prostatitis.

Imaging Studies

  • Transrectal ultrasonography 
    • This study is not helpful unless an abscess is present. Abscesses are extremely rare, but if present, patients may also have a high fever and appear quite ill. CT scanning may also be helpful in this situation if transrectal ultrasonography is not available. MRI may also be used but is usually not as readily available in most acute situations.
    • Transrectal ultrasonography findings may also help identify prostatic stones. In certain patients with frequent recurrences, prostatic stones may be a contributing factor in CBP.

Procedures

  • Prostate biopsy  
    • This is the most definitive but least practical modality used to diagnose bacterial prostatitis. It is also potentially dangerous for the patient.
    • Viewing the specimen under microscopy can help identify a focal infiltration of inflammatory cells into the prostatic stroma. The specimen also serves as a source from which to culture organisms. However, in the face of an active infection such as acute prostatitis, performing a biopsy could precipitate sepsis. Therefore, prostate biopsy is not recommended as a diagnostic modality.
    • On the other hand, category IV prostatitis is diagnosed using prostate biopsy. Category IV prostatitis is asymptomatic but may be responsible for elevations in PSA levels, resulting in the need for a diagnostic biopsy to help exclude prostate cancer.
  • If the patient has frequent recurrences of chronic prostatitis, other tests may help exclude an anatomic obstruction due to prostatic hyperplasia, urinary stricture disease, or bladder neck dysfunction. If this is the case, appropriate treatment (eg, transurethral incision of a urethral stricture, transurethral resection of the prostate or bladder neck) may be indicated.
  • Retrograde urethrography, uroflowmetry, and postvoid residual testing are described as follows:  
    • Retrograde urethrography is performed to help confirm the presence of a urethral stricture. It is performed by injecting contrast into the urethral meatus and obtaining pelvic radiography. If a stricture is present, narrowing of urethral caliber is observed.
    • Uroflowmetry is a simple urodynamic test to help evaluate the rate of urine flow over time. It is used in patients with prostatitis to help evaluate for obstruction secondary to a urethral stricture or prostatic enlargement. Results are obtained in graphical form. Normal study results show a rapid rise to a peak and then a gradual drop-off back to baseline. A urethral stricture is indicated by a rapid rise to a low point, a plateau for the remainder of the study, and then a drop-off at the termination of the study. In prostatic enlargement, a wide variety of patterns is present, but the peak flow is usually less than 15 mL/s, and a stop-start pattern may also be present. To help delineate abnormalities and to differentiate a stricture from prostatic enlargement, cystoscopy should be performed.
    • Postvoid residual testing measures the volume of urine left in the bladder immediately after voiding. This volume can be measured by catheterizing the bladder or by using a bladder scanner. Although the results are nonspecific, they can give clues to the presence of lower tract dysfunction, which may require surgical intervention to relieve prostatic obstruction or urethral stricture.

Histologic Findings

Chronic inflammation is common after biopsy specimens have been obtained to help evaluate for prostate cancer. Findings usually include large focal lymphocytic infiltrates amid the normal prostatic stroma; however, biopsy rarely, if ever, is used to diagnose prostatitis. If an asymptomatic patient is found to have inflammation in the prostatic tissue, this is categorized as category IV prostatitis, ie, asymptomatic inflammatory prostatitis.

More on Chronic Bacterial Prostatitis

Overview: Chronic Bacterial Prostatitis
Differential Diagnoses & Workup: Chronic Bacterial Prostatitis
Treatment & Medication: Chronic Bacterial Prostatitis
Follow-up: Chronic Bacterial Prostatitis
Multimedia: Chronic Bacterial Prostatitis
References
Further Reading

References

  1. McNaughton Collins M, Pontari MA, O'Leary MP, Calhoun EA, Santanna J, Landis JR, et al. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med. Oct/2001;16(10):656-62. [Medline].

  2. Nickel JC, Shoskes D, Wang Y, Alexander RB, Fowler JE Jr, Zeitlin S, et al. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome?. J Urol. Jul 2006;176(1):119-24. [Medline].

  3. Kaplan SA, Volpe MA, Te AE. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol. Jan 2004;171(1):284-8. [Medline].

  4. Dennis LK, Lynch CF, Torner JC. Epidemiologic association between prostatitis and prostate cancer. Urology. Jul 2002;60(1):78-83. [Medline].

  5. Roberts RO, Bergstralh EJ, Bass SE, Lieber MM, Jacobsen SJ. Prostatitis as a risk factor for prostate cancer. Epidemiology. Jan 2004;15(1):93-9. [Medline].

  6. Association of Genitourinary Medicine, Medical Society for the Study of Venereal Diseases. National guideline for the management of prostatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex Transm Infect. Aug 1999;75 Suppl 1:S46-50. [Medline].

  7. Britton JJ, Carson CC. Prostatitis. AUA Update Series. 1998;17:154-9.

  8. Collins MM, Stafford RS, O'Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol. Apr 1998;159(4):1224-8. [Medline].

  9. Kirby RS, ed. An Atlas of Prostatic Diseases. Boca Raton, Fla: CRC Press; 1997:11-24.

  10. Lipsky BA. Prostatitis and urinary tract infection in men: what's new; what's true?. Am J Med. Mar 1999;106(3):327-34. [Medline].

  11. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, Nickel JC, Calhoun EA, Pontari MA, et al. The National Institutes of Health chronic prostatitis symptom index: developmentand validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. Aug 1999;162(2):369-75. [Medline].

  12. Meares EM. Prostatitis: a review. Urol Clin North Am. 1975;2:3-27.

  13. Nickel JC. Prostatitis. In: Mulholland SG, ed. Antibiotic Therapy in Urology. Philadelphia, Pa: Lippincott-Raven; 1996:57-69.

  14. Schaeffer AJ, Landis JR, Knauss JS, Propert KJ, Alexander RB, Litwin MS, et al. Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J Urol. Aug 2002;168(2):593-8. [Medline].

  15. Shoskes DA, Shahed A. Presence of Bacterial Signal in Expressed Prostatic Secretions Predicts Response to Antibiotic Therapy in Men with the Chronic Pelvic Pain Syndrome. J Urol. 2000;163(4):99A.

  16. Spaine DM, Mamizuka EM, Cedenho AP. Microbiological Aerobic Studies of the Normal Male Urethra. J Urol. 1998;161(4):33A.

Further Reading

For additional information, see Medscape’s Prostatitis Resource Center.

Keywords

chronic bacterial prostatitis, chronic prostatitis, CBP, urinary tract infection, UTI, prostatitis symptom complex, nonbacterial prostatitis, non-bacterial prostatitis, urethral stricture, acute prostatitis, prostatic stones, prostate cancer, urinary stricture disease, bladder neck obstruction

Contributor Information and Disclosures

Author

Sunil K Ahuja, MD, Chief of Minimally Invasive Urology, Department of Urology, Staff Urologist, Santa Teresa Community Hospital
Sunil K Ahuja, MD is a member of the following medical societies: American Urological Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

CME Editor

J Stuart Wolf, Jr, MD, FACS, David A Bloom Professor of Urology, Director, Division of Minimally Invasive Urology, Department of Urology, University of Michigan Medical Center
J Stuart Wolf, Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Medical Association, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, and Society of University Urologists
Disclosure: Terumo Corporation Consulting fee Consulting; Omeros Corporation Consulting fee Consulting

Chief Editor

Edward David Kim, MD, FACS, Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center
Edward David Kim, MD, FACS is a member of the following medical societies: American College of Surgeons, American Society for Reproductive Medicine, American Society of Andrology, American Urological Association, and Tennessee Medical Association
Disclosure: Lilly Consulting fee Consulting

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.